NCT05467033View on ClinicalTrials.gov

Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin

PHASE3RecruitingINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Kidney Biopsy
Interventions
DRUG

Desmopressin

desmopressin 0,3ug/kg in 100ml 0,9% NaCl managed as intravenous infusion;

DRUG

intravenous infusion NaCl

0,9% NaCl managed as intravenous infusion

Trial Locations (1)

15-276

RECRUITING

II Department of Nephrology and Hypertension, Bialystok

All Listed Sponsors
lead

Medical University of Bialystok

OTHER